Because Expertise Matters
Join Cyberounds®, an online education community for health professionals Sign Up

Log In

Pulmonary Medicine

Idiopathic Pulmonary Fibrosis

This month, Harold R. Collard, M.D., and Talmadge E. King, Jr., M.D., discuss

CME credit is no longer available for this conference.

Course Authors

Harold R. Collard, M.D., and Talmadge E. King, Jr., M.D.

Dr. Collard is Assistant Clinical Professor and Dr. King is Professor and Chair, Department of Medicine, UCSF School of Medicine, San Francisco, California.

Within the past 12 months, Dr. Collard has been a consultant to InterMune and Dr. King has been a consultant to Alexz, Actelion, AstraZeneca, Biogen, Boehringer Ingelheim, Centocor, CoTherix, FibroGen, GlaxoSmithKline, Genentech, Genzyme, Human Genome Sciences, InterMune, Merck, Millennium Pharmaceutical, Nekta, Otsuka America and Serono International.

Release Date: 06/07/2006

 
Learning Objectives

Upon completion of this Cyberounds®, you should be able to:

  • Discuss the current approach to the diagnosis of idiopathic pulmonary fibrosis

  • Describe the natural history of idiopathic pulmonary fibrosis and how to approach prognosis

  • Describe the data behind potential therapies for idiopathic pulmonary fibrosis and establish an approach to management that is evidence-based.

 

TERMS AND CONDITIONS

This conference may include discussion of commercial products and services.

The opinions expressed herein are those of the authors and do not necessarily represent the views of the sponsor or its publisher. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

 

Please click below to accept the terms.

Courses You Might Like

Cystic Fibrosis -- No Longer Just a Disease of Pediatric Medicine

Emerging research suggests target-specific therapies for managing cystic fibrosis.
Authors: Arindam Singha, M.D., and Stephen E. Kirkby, M.D.
View Course
More

Asthma Management: A Multi-Faceted Approach

Asthma action plans are designed to be individualized and developed jointly with the patient, and may be based on symptoms or peak flow measurements.
Authors: Cathy G. Benninger, R.N., M.S., C.N.P., and Jennifer W. McCallister, M.D.
View Course
More

Idiopathic Pulmonary Fibrosis

Table 1. Clinical Strategies for the Improvement of Asthma Control.
Authors: Ganesh Raghu, M.D., and Samuel G. Rayner, M.D.
View Course
More

The Role of Matrix Metalloproteinases (MMPs) in COPD

Elaboration of matrix metalloproteinases (MMPs), zinc-dependent proteases, within the airways contributes to COPD.
Authors: Robert Foronjy, M.D., and Jeanine D'Armiento, M.D., Ph.D.
View Course
More

Acute Lung Injury and the Acute Respiratory Distress Syndrome

ALI complicates a variety of medical and surgical conditions, most commonly severe sepsis, pneumonia and massive trauma.
Authors: Chirag V. Shah, M.D., M.S., and Jason D. Christie, M.D., M.S.
View Course
More

The Diagnosis and Management of Venous Thromboembolism

This month, Victor F. Tapson, M.D., discusses

present in acute PE. The diagnostic utility of plasma measurements of circulating D-dimer (a specific derivative of cross-linked fibrin) has been extensively evaluated in patients with PE. A number of D-dimer assays are available, and the sensitivity and specificity of these assays vary. A positive D-dimer test means that…
Authors: Victor F. Tapson, M.D.
View Course
More